Marjolein K Sechterberger1, Sigrid C J van Steen2, Esther M N Boerboom3, Peter H J van der Voort4, Rob J Bosman5, Joost B L Hoekstra6, J Hans DeVries7. 1. Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: m.k.sechterberger@amc.uva.nl. 2. Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: s.c.vansteen@amc.uva.nl. 3. Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: e.m.boerboom@amc.uva.nl. 4. Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; TIAS School for Business and Society, Tilburg University, Tilburg, The Netherlands. Electronic address: p.h.j.vandervoort@olvg.nl. 5. Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Electronic address: r.j.bosman@olvg.nl. 6. Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: j.b.hoekstra@amc.uva.nl. 7. Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: j.h.devries@amc.uva.nl.
Abstract
PURPOSE: Although the course of disease of type 1 and type 2 diabetes differs, the distinction is rarely made when patients are admitted to the intensive care unit (ICU). Here, we report patient- and admission-related characteristics in relation to glycemic measures of patients with type 1 and type 2 diabetes admitted to the ICU. MATERIALS AND METHODS: A retrospective chart review was performed of 1574 patients with diabetes admitted between 2004 and 2011 to our ICU. Glycemic measures included mean glucose, the incidence of hypoglycemia and hyperglycemia, percentage of glucose values in/below/above target, and glucose variability. The ICU and hospital mortality were secondary outcomes. RESULTS: We classified 2% (n=27) of patients as having type 1 diabetes and 98% (n=1547) as having type 2 diabetes. Patients with type 1 diabetes were significantly younger, had a lower body mass index, and were more frequently admitted to the ICU for medical diagnoses. No differences in glycemic measures were found, apart from a 20% higher glucose variability in the type 1 diabetes group. CONCLUSIONS: Patients with type 1 diabetes showed a higher glucose variability, but overall glycemic control was not different between patients with type 1 and type 2 diabetes. Very few diabetes patients admitted to the ICU have type 1 diabetes.
PURPOSE: Although the course of disease of type 1 and type 2 diabetes differs, the distinction is rarely made when patients are admitted to the intensive care unit (ICU). Here, we report patient- and admission-related characteristics in relation to glycemic measures of patients with type 1 and type 2 diabetes admitted to the ICU. MATERIALS AND METHODS: A retrospective chart review was performed of 1574 patients with diabetes admitted between 2004 and 2011 to our ICU. Glycemic measures included mean glucose, the incidence of hypoglycemia and hyperglycemia, percentage of glucose values in/below/above target, and glucose variability. The ICU and hospital mortality were secondary outcomes. RESULTS: We classified 2% (n=27) of patients as having type 1 diabetes and 98% (n=1547) as having type 2 diabetes. Patients with type 1 diabetes were significantly younger, had a lower body mass index, and were more frequently admitted to the ICU for medical diagnoses. No differences in glycemic measures were found, apart from a 20% higher glucose variability in the type 1 diabetes group. CONCLUSIONS:Patients with type 1 diabetes showed a higher glucose variability, but overall glycemic control was not different between patients with type 1 and type 2 diabetes. Very few diabetespatients admitted to the ICU have type 1 diabetes.
Authors: Linda T Muijs; Caterina Racca; Maartje de Wit; Annelies Brouwer; Thomas H Wieringa; Ralph de Vries; Erik H Serné; Daniël H van Raalte; Femke Rutters; Frank J Snoek Journal: Endocrinol Diabetes Metab Date: 2020-07-14
Authors: María Paula Russo; Santiago Nicolas Marquez Fosser; Cristina María Elizondo; Diego Hernán Giunta; Nora Angélica Fuentes; María Florencia Grande-Ratti Journal: Rev Diabet Stud Date: 2021-11-01
Authors: Meng-Wei Chang; Chun-Ying Huang; Hang-Tsung Liu; Yi-Chun Chen; Ching-Hua Hsieh Journal: Int J Environ Res Public Health Date: 2018-05-15 Impact factor: 3.390